Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

China flag China · Delayed Price · Currency is CNY
17.44
+0.43 (2.53%)
Apr 30, 2026, 1:15 PM CST
Market Cap4.45B +138.9%
Revenue (ttm)1.09B +4.7%
Net Income-91.20M
EPS-0.34
Shares Out261.64M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.61%)
Ex-Dividend DateNov 26, 2025
Volume12,074,606
Average Volume14,954,062
Open16.91
Previous Close17.01
Day's Range16.88 - 18.10
52-Week Range6.59 - 17.86
Beta0.60
RSI62.98
Earnings DateApr 25, 2026

About SHE:300246

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltrat... [Read more]

Sector Healthcare
Founded 1993
Employees 1,335
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300246
Full Company Profile

Financial Performance

In 2025, SHE:300246's revenue was 1.10 billion, an increase of 3.29% compared to the previous year's 1.06 billion. Losses were -69.43 million, -2.82% less than in 2024.

Financial Statements